Clinical Trials Browser

Active not recruiting × OTHER × Edema × Clear all

NCT02411656 2026-01-23

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Phase 2 Active not recruiting

71 enrolled 11 charts

Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02876107 2025-10-10

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05142800 2025-05-22

Screening For BCRL In Targeted Therapy For Breast Cancer

Active not recruiting

Breast Cancer Lymphedema, Breast Neoplasms, Edema, Lymphedema

NCT02306538 2023-02-14

EMBRACE-MRI

Active not recruiting

Breast Neoplasms, Cicatrix, Edema, Inflammation